Lecture 3 Lm

  • April 2020
  • PDF

This document was uploaded by user and they confirmed that they have the permission to share it. If you are author or own the copyright of this book, please report to us by using this DMCA report form. Report DMCA


Overview

Download & View Lecture 3 Lm as PDF for free.

More details

  • Words: 853
  • Pages: 30
Lecture 3 Impaired Glucose Metabolism: Diabetes Mellitus

• Normal plasma glucose: 3.9-8.3 mM • Plasma glucose is tightly regulated by hormones: Insulin: ↓ Plasma glucose

• Glucagon Epinephrine Cortisol Growth hormone

↑ Plasma glucose

Regulation of Blood Glucose by Insulin High blood glucose

Blood vessel

Muscle

+

+

Pancreas

Insulin

+ Adipose tissue

_

Glucagon

_ Liver Glucose production

↑Glucose uptake ↑Glucose storage Fig 15 handout

Regulation of Blood Glucose by Glucagon Blood vessel Pancreas

+ Glucagon

Low blood glucose

Peripheral tissues Glucose

+

Glucose production

Liver

Fig 15 handout

Diabetes Mellitus Definition: A chronic metabolic disorder characterized by hyperglycemia resulting from impaired insulin secretion and/or action.

Hyperglycemia: ↑ in blood glucose

• Diabetes = “siphon” or “running through” Large urine volume

• Mellitus = sweet Glucose in urine

• Diabetes is the most common endocrine disorder.

Criteria for Diagnosis: Each of the following:

• Symptoms + random plasma glucose >11.1 mM (200 mg/dl)

• Fasting plasma glucose >7 mM (126 mg/dl) • Oral glucose tolerance test (OGTT): 2-h plasma glucose >11.1 mM (200 mg/dl)

Classification of Diabetes Type 1 Diabetes - Insulin-dependent diabetes mellitus (IDDM) - Juvenile-onset diabetes Type 2 Diabetes - Non-insulin-dependent diabetes mellitus (NIDDM) - Adult-onset diabetes

Characteristics of Type 1 Diabetes - Hypoinsulinemia (↓insulin levels) - 10% of diabetic cases - Patients require insulin - Age of onset: childhood - Ketoacidosis (↑ketones in blood)

Etiology of Type 1 Diabetes • Autoimmune disease • Selective destruction of β cells by T cells • Several circulating antibodies against β cells • Cause of autoimmune attack: unknown • Both genetic & environmental factors are important

Etiology of Type 1 Diabetes Environmental Factors

e.g.

Viruses Coxsackie Mumps Rubella

Babies

Cow milk

May attack β cells

Nutrients e.g. Cow milk

Antibodies against cow insulin Closely resembles human insulin

Genetic Factors • There is a close correlation between type 1 diabetes & some classes of MHC genes

- e.g. genes encoding HLA-DR & HLA-DQ - They can either ↑ the risk of diabetes or protect against the disease MHC: major histocompatibility complex HLA: human leukocyte antigen

Role of HLA Molecules in Antigen Presentation T-cell receptor

HLA molecule

T-cell Antigen Activated Immune response

Antigen presenting cell (APC) Fig 16 handout

Characteristics of Type 2 Diabetes - Impaired insulin action - Insulin secretion is normal or increased - 90% of diabetic cases - Age of onset: adulthood - Associated with obesity - Ketoacidosis: rare - Most patients don’t require insulin

Type 2 Diabetes Impaired Insulin Action

β Cell Dysfunction/Death

ß-Cell ↑ Glucose Production

↓ Glucose Utilization

Impaired Insulin Secretion

Etiology of Type 2 Diabetes • Response to insulin is decreased - ↓glucose uptake (muscle, fat) - ↑glucose production (liver)

• The mechanism of insulin resistance is unclear

• Both genetic & environmental factors are involved

• Post insulin receptor defects

Mechanism of Hyperglycemia in Diabetes Absolute (type 1 diabetes) or relative (type 2 diabetes) insulin deficiency: - An increase in hepatic glucose output - A decrease in peripheral glucose uptake & utilization

Increase in Hepatic Glucose Output ↓insulin ↓inhibitory effect on glucagon secretion ↑glucagon

Liver gluconeogenesis & glycogenolysis ↑ plasma glucose

Decrease in Glucose Uptake Muscle

Adipose tissue

↓insulin

↓insulin

↓glucose & amino acid uptake ↑protein breakdown

↑lipolysis ↓lipogenesis

↑plasma glucose ↑plasma amino acids

↑plasma fatty acids

Glucose Metabolism (Resting State) Fig 17 handout

CNS ∼6 g.h-1

Pancreas Glucagon +

Liver

∼10 g.h-1

Insulin +

Glucose

∼4 g.h-1

Brain

Liver Muscle Fat

Glucose Metabolism (Type 1 Diabetes) Fig 17 handout

CNS ∼6 g.h-1

Pancreas ↑Glucagon +

Liver

>20 g.h-1

Brain Insulin

<1 g.h-1

↑Glucose >14 g.h-1

Kidney

Liver Muscle Fat

Complications of Diabetes Acute complications • Glucosuria: glucose appears in urine • Polyuria: frequent urination • Polydipsia: excessive thirst • Polyphagia: excessive food intake • Ketoacidosis

↓insulin→↑lipolysis→↑fatty acids→liver→ketones

Chronic complications • neuropathy: loss of sensation due to damage of

nerve fibres (e.g. heat, cold, pain) - high blood glucose changes the metabolism of nerve cells - reduced blood flow

Sensory neuropathy

Chronic complications, Cont’d • Cardiovascular disease:

- atherosclerosis - high blood pressure - myocardial infarction

Chronic complications, Cont’d • Retinopathy: damage of retina • Cataract: damage of lens • Both may cause blindness

Chronic complications, Cont’d • Nephropathy:

- has a slow onset - may result in severe kidney failure - follow up: proteinuria

Treatment of Diabetes Type 1 Diabetes

• Insulin therapy - patients need exogenous insulin - insulin can not be administered orally - insulin preparations: porcine, bovine & recombinant human insulin - inhaled powder insulin

Treatment of Type 1 Diabetes, Cont’d • Pancreatic islet transplantation Isolated islets from pancreas are transplanted to the diabetic patients. Advantage: Provides an endogenous source of insulin Disadvantage: Patients need life-time immunosuppressive therapy

Treatment of Diabetes Type 2 Diabetes

• Exercise, diet & weight loss • Oral glucose lowering drugs - stimulate insulin secretion from β cells - suppress liver glucose output - increase insulin sensitivity - slow down glucose absorption from GI tract after meal

Hyperinsulinemia • Insulin excess is characterized by hypoglycemia (↓blood glucose levels)

• Common causes: - high dose of insulin - β cell tumors

• Major symptoms: - depressed brain function unconsciousness death

Related Documents

Lecture 3 Lm
April 2020 3
Lm
May 2020 15
Lm
November 2019 25
Lm
October 2019 22
Lecture 3
June 2020 0
Lecture 3
November 2019 8